JP2014030364A - Dna extraction method - Google Patents
Dna extraction method Download PDFInfo
- Publication number
- JP2014030364A JP2014030364A JP2012170881A JP2012170881A JP2014030364A JP 2014030364 A JP2014030364 A JP 2014030364A JP 2012170881 A JP2012170881 A JP 2012170881A JP 2012170881 A JP2012170881 A JP 2012170881A JP 2014030364 A JP2014030364 A JP 2014030364A
- Authority
- JP
- Japan
- Prior art keywords
- dna
- carrier
- salt concentration
- aqueous solution
- adsorbed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 238000007400 DNA extraction Methods 0.000 title abstract description 7
- 102000053602 DNA Human genes 0.000 claims abstract description 50
- 108020004414 DNA Proteins 0.000 claims abstract description 50
- 238000005406 washing Methods 0.000 claims abstract description 28
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 27
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 27
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 27
- 230000003196 chaotropic effect Effects 0.000 claims abstract description 16
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 13
- 239000007790 solid phase Substances 0.000 claims abstract description 11
- 239000006166 lysate Substances 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims description 34
- 239000007864 aqueous solution Substances 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000002736 nonionic surfactant Substances 0.000 claims description 4
- 150000002357 guanidines Chemical class 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000006249 magnetic particle Substances 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 238000010828 elution Methods 0.000 description 14
- 229920002477 rna polymer Polymers 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 229960000789 guanidine hydrochloride Drugs 0.000 description 4
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000009089 cytolysis Effects 0.000 description 3
- -1 for example Chemical compound 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 241000511343 Chondrostoma nasus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Abstract
【課題】新規なDNAの抽出方法を提供すること。
【解決手段】デオキシリボ核酸(DNA)を含む試料に、カオトロピック物質を含有する溶解液および核酸結合性固相担体を混合して、DNAを担体上に吸着させる工程と、DNAを吸着させた担体を、有機溶媒を含まない洗浄液で洗浄する工程と、担体に吸着したDNAを70℃より高い温度で溶出液中に溶出させる工程と、を行う。
【選択図】 なしA novel DNA extraction method is provided.
A sample containing deoxyribonucleic acid (DNA) is mixed with a lysate containing a chaotropic substance and a nucleic acid-binding solid phase carrier to adsorb the DNA on the carrier, and the carrier on which the DNA is adsorbed. The step of washing with a washing solution not containing an organic solvent and the step of eluting the DNA adsorbed on the carrier into the eluate at a temperature higher than 70 ° C. are performed.
[Selection figure] None
Description
本発明は、DNAの抽出方法に関する。 The present invention relates to a method for extracting DNA.
シリカ粒子等の核酸結合性固相担体とカオトロピック剤を用いて、生体材料からより簡
便に核酸を抽出する方法が、Boomらにより報告された(非特許文献1参照)。このBoomら
の方法を含め、シリカ等の核酸結合性固相担体とカオトロピック剤を用いて核酸を担体に
吸着させ、抽出する方法は、主に、(1)カオトロピック剤存在下、核酸結合性固相担体
に核酸を吸着させる工程(吸着工程)、(2)非特異的に結合した夾雑物及びカオトロピ
ック剤を除くため、洗浄液にて核酸の吸着した担体を洗浄する工程(洗浄工程)、および
(3)水または低塩濃度緩衝液にて核酸を担体から溶出させる工程(溶出工程)の3工程
からなる。ここで(2)の洗浄液としては、カオトロピック剤を溶かし込み、さらに、核
酸の担体からの溶出を防ぐため、従来から、水溶性有機溶媒、特にエタノールを50〜8
0%程度の割合で含有する水または低塩濃度緩衝液が用いられている。
Boom et al. Reported a method for more easily extracting nucleic acids from biomaterials using a nucleic acid-binding solid phase carrier such as silica particles and a chaotropic agent (see Non-Patent Document 1). Including the method of Boom et al., A method of adsorbing and extracting a nucleic acid on a carrier using a nucleic acid-binding solid phase carrier such as silica and a chaotropic agent mainly includes (1) a nucleic acid-binding solid phase in the presence of a chaotropic agent. A step of adsorbing nucleic acid to the phase carrier (adsorption step), (2) a step of washing the carrier adsorbed with nucleic acid with a washing solution (washing step) to remove non-specifically bound impurities and chaotropic agents, and ( 3) It consists of three steps of eluting nucleic acid from the carrier with water or a low salt concentration buffer (elution step). Here, as the washing liquid of (2), in order to dissolve the chaotropic agent and prevent elution of the nucleic acid from the carrier, conventionally, a water-soluble organic solvent, particularly ethanol, is used in an amount of 50 to 8.
Water or a low salt concentration buffer containing about 0% is used.
しかしながら、この水溶性有機溶媒が(3)の工程に残留した場合、抽出液を酵素処理
する際に酵素反応が阻害されるため、通常、エタノールを含む水溶液での洗浄後は、必要
に応じて100%エタノール、あるいは、さらに揮発性の高いアセトン等で洗浄し、その
後、乾燥させて、有機溶媒を系から完全に取り除く操作が行われている。この乾燥は時間
を要するのみでなく、乾燥時間が不十分であればエタノールの残留につながり、過度の場
合には、核酸が乾燥しすぎて固化するため、溶出が困難になり、結果的に核酸回収量の低
下や再現性の低下に繋がることが知られている。このように有機溶媒の使用は、その乾燥
の程度を見極めにくいのみならず、エタノールやアセトンといった有機溶媒は引火性及び
揮発性を有するため、特に操作の自動化を考えた場合には、出火等の危険性も考えられる
。
However, when this water-soluble organic solvent remains in the step (3), the enzyme reaction is inhibited when the extract is treated with an enzyme, and therefore, usually after washing with an aqueous solution containing ethanol, as necessary. An operation of washing with 100% ethanol or acetone with higher volatility and then drying to completely remove the organic solvent from the system is performed. Not only does this drying take time, but if the drying time is insufficient, ethanol will remain, and if it is excessive, the nucleic acid will be too dry and solidified, making it difficult to elute, resulting in nucleic acid. It is known that this leads to a decrease in the recovery amount and reproducibility. In this way, the use of organic solvents not only makes it difficult to determine the degree of drying, but organic solvents such as ethanol and acetone are flammable and volatile. There is also a danger.
そこで、核酸を担体に吸着させた後、(2)の洗浄工程で、エタノール等の有機溶媒を
全く含まない水または低塩濃度緩衝液で担体を洗浄し、(3)の溶出工程で、50〜70
℃で、水または低塩濃度緩衝液で核酸を溶出することによって、リボ核酸(RNA)を抽
出する方法が開発された(特許文献1参照)。
Therefore, after the nucleic acid is adsorbed on the carrier, the carrier is washed with water or a low salt concentration buffer solution containing no organic solvent such as ethanol in the washing step (2), and 50% in the elution step (3). ~ 70
A method has been developed for extracting ribonucleic acid (RNA) by eluting the nucleic acid with water or a low salt concentration buffer at 0 ° C. (see Patent Document 1).
本発明は、新規なデオキシリボ核酸(DNA)の抽出方法を提供することを目的とする
。
An object of the present invention is to provide a novel method for extracting deoxyribonucleic acid (DNA).
これまで、Boom法において核酸を担体に吸着させた後、(2)の洗浄工程で、エタノー
ル等の有機溶媒を事実上含まない水または低塩濃度緩衝液で担体を洗浄すると、デオキシ
リボ核酸(DNA)は、リボ核酸(RNA)より先に担体から遊離するため、(3)の溶
出工程で、50〜70℃で、水または低塩濃度水溶液で核酸を溶出することによって、D
NAの混入が無くRNAを単離できると考えられていた(特開平11−146783号公
開公報)。しかしながら、本発明者は、(3)の溶出工程で、80℃以上で、水または低
塩濃度水溶液で核酸を溶出することによって、DNAが抽出できることを見出し、本発明
の完成に至った。
Until now, after adsorbing a nucleic acid on a carrier in the Boom method, in the washing step (2), the carrier is washed with water or a low salt concentration buffer that does not substantially contain an organic solvent such as ethanol. ) Is released from the carrier prior to ribonucleic acid (RNA), and therefore, in the elution step of (3), the nucleic acid is eluted with water or a low salt concentration aqueous solution at 50 to 70 ° C.
It was thought that RNA could be isolated without contamination of NA (Japanese Patent Application Laid-Open No. 11-146783). However, the present inventors have found that DNA can be extracted by elution of nucleic acid with water or a low salt concentration aqueous solution at 80 ° C. or higher in the elution step (3), and the present invention has been completed.
本発明の一実施形態は、DNAを含む試料に、カオトロピック物質を含有する溶解液お
よび核酸結合性固相担体を混合して、DNAを前記担体上に吸着させる工程と、前記DN
Aを吸着させた前記担体を有機溶媒を含まない洗浄液で洗浄する工程と、前記担体に吸着
したDNAを70℃より高い温度で溶出液中に溶出させる工程と、を含むDNAの抽出方
法である。前記洗浄液は、水または低塩濃度水溶液であってもよいが、前記低塩濃度水溶
液の塩濃度が100mM以下であることが好ましい。また、前記溶出液は、水または低塩
濃度水溶液であってもよいが、前記低塩濃度水溶液の塩濃度が100mM以下であること
が好ましい。前記担体に吸着したDNAは、100℃未満で溶出させてもよい。前記溶解
液は、3〜7Mのグアニジン塩、0〜5%の非イオン性界面活性剤、0〜0.2mMのE
DTA、0〜0.2Mの還元剤を含有する中性溶解液であってもよい。前記担体は、磁性
粒子であってもよい。
In one embodiment of the present invention, a sample containing DNA is mixed with a lysate containing a chaotropic substance and a nucleic acid-binding solid phase carrier, and the DNA is adsorbed on the carrier;
A method for extracting DNA, comprising: a step of washing the carrier on which A is adsorbed with a washing solution not containing an organic solvent; and a step of eluting the DNA adsorbed on the carrier in an eluent at a temperature higher than 70 ° C. . The cleaning liquid may be water or a low salt concentration aqueous solution, but the salt concentration of the low salt concentration aqueous solution is preferably 100 mM or less. Moreover, although the eluate may be water or a low salt concentration aqueous solution, the salt concentration of the low salt concentration aqueous solution is preferably 100 mM or less. The DNA adsorbed on the carrier may be eluted at less than 100 ° C. The lysate is 3-7 M guanidine salt, 0-5% nonionic surfactant, 0-0.2 mM E.
It may be a neutral solution containing DTA, 0 to 0.2 M reducing agent. The carrier may be magnetic particles.
本発明によって、新規なDNAの抽出方法を提供することが可能になった。 The present invention has made it possible to provide a novel DNA extraction method.
実施の形態及び実施例に特に説明がない場合には、M. R. Green & J. Sambrook (Ed.
), Molecular cloning, a laboratory manual (4th edition), Cold Spring Harbor Pres
s, Cold Spring Harbor, New York (2012); F. M. Ausubel, R. Brent, R. E. Kingston,
D. D. Moore, J.G. Seidman, J. A. Smith, K. Struhl (Ed.), Current Protocols in M
olecular Biology, John Wiley & Sons Ltd.などの標準的なプロトコール集に記載の方法
、あるいはそれを修飾したり、改変した方法を用いる。また、市販の試薬キットや測定装
置を用いる場合には、特に説明が無い場合、それらに添付のプロトコールを用いる。
Unless otherwise described in the embodiments and examples, MR Green & J. Sambrook (Ed.
), Molecular cloning, a laboratory manual (4th edition), Cold Spring Harbor Pres
s, Cold Spring Harbor, New York (2012); FM Ausubel, R. Brent, RE Kingston,
DD Moore, JG Seidman, JA Smith, K. Struhl (Ed.), Current Protocols in M
A method described in a standard protocol collection such as olecular Biology, John Wiley & Sons Ltd., or a modified or modified method thereof is used. In addition, when using commercially available reagent kits and measuring devices, unless otherwise explained, protocols attached to them are used.
なお、本発明の目的、特徴、利点、及びそのアイデアは、本明細書の記載により、当業
者には明らかであり、本明細書の記載から、当業者であれば、容易に本発明を再現できる
。以下に記載された発明の実施の形態及び具体的に実施例などは、本発明の好ましい実施
態様を示すものであり、例示又は説明のために示されているのであって、本発明をそれら
に限定するものではない。本明細書で開示されている本発明の意図並びに範囲内で、本明
細書の記載に基づき、様々な改変並びに修飾ができることは、当業者にとって明らかであ
る。
The objects, features, advantages, and ideas of the present invention will be apparent to those skilled in the art from the description of the present specification, and those skilled in the art can easily reproduce the present invention from the description of the present specification. it can. The embodiments and specific examples of the invention described below show preferred embodiments of the present invention, and are shown for illustration or explanation. It is not limited. It will be apparent to those skilled in the art that various modifications and variations can be made based on the description of the present specification within the spirit and scope of the present invention disclosed herein.
==DNA抽出用試薬など==
本発明にかかるデオキシリボ核酸(DNA)の抽出方法は、DNAを含む試料に、カオ
トロピック物質を含有する溶解液および核酸結合性固相担体を混合して、DNAを担体上
に吸着させる工程(吸着工程)と、DNAを吸着させた担体を有機溶媒を含まない洗浄液
で洗浄する工程(洗浄工程)と、担体に吸着したDNAを70℃より高い温度で溶出液中
に溶出させる工程(溶出工程)と、を含む。
== Reagent for DNA extraction, etc. ==
In the method for extracting deoxyribonucleic acid (DNA) according to the present invention, a sample containing DNA is mixed with a lysate containing a chaotropic substance and a nucleic acid-binding solid phase carrier, and the DNA is adsorbed on the carrier (adsorption step). ), A step of washing the carrier on which the DNA is adsorbed with a washing solution not containing an organic solvent (washing step), and a step of eluting the DNA adsorbed on the carrier into the eluate at a temperature higher than 70 ° C. (elution step) ,including.
DNAを抽出する試料は、DNAを含んでいれば特に限定されず、細胞や、組織などの
細胞塊などの生体試料、ウイルス、合成DNA、一旦単離したDNAに不純物や夾雑物が
混入した試料などであってもよい。
The sample from which DNA is extracted is not particularly limited as long as it contains DNA, a biological sample such as a cell or a cell mass such as a tissue, a virus, a synthetic DNA, or a sample in which impurities or impurities are mixed into DNA once isolated It may be.
カオトロピック物質は、水溶液中でカオトロピックイオン(イオン半径の大きな1価の
陰イオン)を生じ、疎水性分子の水溶性を増加させる作用を有しており、DNAの固相担
体への吸着に寄与するものであれば、特に限定されない。具体的には、グアニジンチオシ
アン酸塩、グアニジン塩酸塩、ヨウ化ナトリウム、ヨウ化カリウム、過塩素酸ナトリウム
等が挙げられるが、これらのうち、タンパク質変成作用の強いグアニジンチオシアン酸塩
またはグアニジン塩酸塩が好ましい。これらのカオトロピック物質の使用濃度は、各物質
により異なり、例えば、グアニジンチオシアン酸塩を使用する場合には、3〜5.5Mの
範囲で、グアニジン塩酸塩を使用する場合は、5M以上で使用するのが好ましい。
The chaotropic substance generates chaotropic ions (monovalent anions having a large ionic radius) in an aqueous solution and has an action of increasing the water solubility of hydrophobic molecules, contributing to adsorption of DNA to a solid phase carrier. If it is a thing, it will not specifically limit. Specific examples include guanidine thiocyanate, guanidine hydrochloride, sodium iodide, potassium iodide, sodium perchlorate and the like. preferable. The concentration of these chaotropic substances used varies depending on each substance. For example, when guanidine thiocyanate is used, it is in the range of 3 to 5.5M, and when guanidine hydrochloride is used, it is used at 5M or more. Is preferred.
溶解液は、このようなカオトロピック物質を含有すれば特に限定されないが、細胞膜の
破壊あるいは細胞中に含まれるタンパク質を変性させる目的で界面活性剤を含有させても
よい。この界面活性剤としては、一般に細胞等からの核酸抽出に使用されるものであれば
特に限定されないが、具体的には、Triton−Xなどのトリトン系界面活性剤やTw
een20などのツイーン系界面活性剤のような非イオン性界面活性剤、N‐ラウロイル
サルコシンナトリウム(SDS)等の陰イオン性界面活性剤が挙げられるが、特に非イオ
ン性界面活性剤を、0.1〜2%の範囲となるように使用するのが好ましい。さらに、溶
解液には、2−メルカプトエタノールあるいはジチオスレイトール等の還元剤を含有させ
ることが好ましい。溶解液は、緩衝液であっても良いが、pH6〜8の中性であることが
好ましい。これらのことを考慮し、具体的には、3〜7Mのグアニジン塩、0〜5%の非
イオン性界面活性剤、0〜0.2mMのEDTA、0〜0.2Mの還元剤などを含有する
ことが好ましい。
The lysing solution is not particularly limited as long as it contains such a chaotropic substance, but it may contain a surfactant for the purpose of disrupting cell membranes or denaturing proteins contained in cells. The surfactant is not particularly limited as long as it is generally used for nucleic acid extraction from cells or the like. Specifically, a Triton surfactant such as Triton-X or Tw
Nonionic surfactants such as tween surfactants such as een20 and anionic surfactants such as sodium N-lauroyl sarcosine (SDS) can be mentioned. It is preferable to use it in the range of 1 to 2%. Furthermore, it is preferable that the solution contains a reducing agent such as 2-mercaptoethanol or dithiothreitol. The lysis solution may be a buffer solution, but is preferably neutral at pH 6-8. In consideration of these matters, specifically, it contains 3 to 7 M guanidine salt, 0 to 5% nonionic surfactant, 0 to 0.2 mM EDTA, 0 to 0.2 M reducing agent and the like. It is preferable to do.
核酸結合性固相担体は、カオトロピックイオンの存在下で、核酸を吸着すなわち可逆的
な物理的結合により保持することができる親水性表面を有する固体であれば、特に限定さ
れない。具体的には、二酸化珪素を含有する物質、例えば、シリカ、ガラス、珪藻土、あ
るいはこれらを化学的修飾により表面処理を施したものが好ましく、磁性体や超常磁性金
属酸化物等との複合体がより好ましい。化学的修飾により表面処理を施す場合は、核酸と
の可逆的な結合を妨げない程度に、適度な陽性電荷を帯びさせてもよい。
The nucleic acid-binding solid phase carrier is not particularly limited as long as it is a solid having a hydrophilic surface capable of adsorbing nucleic acid in the presence of chaotropic ions, that is, holding the nucleic acid by reversible physical binding. Specifically, a substance containing silicon dioxide, for example, silica, glass, diatomaceous earth, or those subjected to surface treatment by chemical modification is preferable, and a complex with a magnetic substance or a superparamagnetic metal oxide is used. More preferred. When surface treatment is performed by chemical modification, an appropriate positive charge may be imparted to the extent that reversible binding to nucleic acids is not hindered.
また、これらの核酸結合性固相の形態としては、粒子、フィルター、バッグ、ディッシ
ュ、反応容器等が具体的に挙げられるが、特に限定されない。これらのうち、吸着と溶出
の効率を考慮すると粒子の形態がより好ましい。その場合の粒径は特に限定されないが、
0.05〜500μmであってもよく、好ましくは1〜100μmであり、特に好ましく
は1〜10μmである。
Specific examples of the nucleic acid-binding solid phase include particles, filters, bags, dishes, reaction vessels, and the like, but are not particularly limited. Among these, the particle form is more preferable in consideration of the efficiency of adsorption and elution. The particle size in that case is not particularly limited,
0.05-500 micrometers may be sufficient, Preferably it is 1-100 micrometers, Most preferably, it is 1-10 micrometers.
洗浄液は、エタノールやイソプロピルアルコール等の有機溶媒およびカオトロピック物
質を事実上含まないものが用いられ、水または低塩濃度水溶液であることが好ましく、低
塩濃度水溶液の場合、緩衝液であることが好ましい。低塩濃度水溶液の塩濃度は、100
mM以下が好ましく、50mM以下がより好ましく、15mM以下が最も好ましい。また
、低塩濃度水溶液の下限は特に無いが、0.1mM以上であることが好ましく、1mM以
上であることがさらに好ましく、10mM以上であることが最も好ましい。また、この溶
液はTriton、Tween、SDSなどの界面活性剤を含有しても良く、pHは特に
限定されない。緩衝液にするための塩は特に限定されないが、トリス、ヘペス、ピペス、
リン酸などの塩が好ましく用いられる。
The washing liquid is substantially free of organic solvents such as ethanol and isopropyl alcohol and chaotropic substances, and is preferably water or a low salt concentration aqueous solution. In the case of a low salt concentration aqueous solution, a buffer solution is preferable. . The salt concentration of the low salt concentration aqueous solution is 100
mM or less is preferred, 50 mM or less is more preferred, and 15 mM or less is most preferred. The lower limit of the low salt concentration aqueous solution is not particularly limited, but is preferably 0.1 mM or more, more preferably 1 mM or more, and most preferably 10 mM or more. Moreover, this solution may contain surfactants, such as Triton, Tween, and SDS, and pH is not specifically limited. The salt for making the buffer is not particularly limited, but Tris, Hepes, Pipes,
A salt such as phosphoric acid is preferably used.
溶出液も、特に限定されないが、水または低塩濃度水溶液が好ましく、エタノールやイ
ソプロピルアルコール等の有機溶媒およびカオトロピック物質を事実上含まないものがよ
り好ましい。低塩濃度水溶液の場合、緩衝液であることが好ましい。低塩濃度水溶液の塩
濃度は、100mM以下が好ましく、50mM以下がより好ましく、15mM以下が最も
好ましい。低塩濃度水溶液の下限は特に無いが、0.1mM以上であることが好ましく、
1mM以上であることがさらに好ましく、10mM以上であることが最も好ましい。緩衝
液にするための塩は特に限定されないが、トリス、ヘペス、ピペス、リン酸などの塩が好
ましく用いられ、TE緩衝液(10mMトリス塩酸緩衝液、1mM EDTA、pH8.
0)が最も好ましい。なお、洗浄液と溶出液は、同じであっても異なっていても良い。
The eluate is not particularly limited, but water or an aqueous solution having a low salt concentration is preferable, and an eluent substantially free of an organic solvent such as ethanol or isopropyl alcohol and a chaotropic substance is more preferable. In the case of a low salt concentration aqueous solution, a buffer solution is preferred. The salt concentration of the low salt concentration aqueous solution is preferably 100 mM or less, more preferably 50 mM or less, and most preferably 15 mM or less. Although there is no particular lower limit of the low salt concentration aqueous solution, it is preferably 0.1 mM or more,
It is more preferably 1 mM or more, and most preferably 10 mM or more. The salt for making the buffer is not particularly limited, but salts such as Tris, Hepes, Pipes, and phosphoric acid are preferably used, and TE buffer (10 mM Tris-HCl buffer, 1 mM EDTA, pH 8.
0) is most preferred. Note that the washing solution and the elution solution may be the same or different.
==DNA抽出方法==
具体的には、以下の様にしてDNAを抽出すれば良い。
== DNA extraction method ==
Specifically, DNA may be extracted as follows.
まず、溶解工程として、適量の溶解液に、DNAを抽出する試料及び核酸結合性固相担
体を混合し、ホモジェナイザーやボルテックス・ミキサーなどによって試料を破砕し、D
NAを担体に吸着させる。
First, as a lysis step, a sample for extracting DNA and a nucleic acid-binding solid phase carrier are mixed in an appropriate amount of lysate, and the sample is crushed by a homogenizer, a vortex mixer, or the like.
NA is adsorbed on the carrier.
次に、洗浄工程として、非特異的に担体に吸着した夾雑物を除去するため、DNAが吸
着した担体を、適量の溶解液で洗浄することが好ましい。洗浄回数は特に限定されないが
、1回〜数回洗浄すればよい。
Next, as a washing step, in order to remove non-specifically adsorbed impurities on the carrier, it is preferable to wash the carrier on which the DNA is adsorbed with an appropriate amount of lysis solution. Although the number of times of washing is not particularly limited, it may be washed once to several times.
ここでいう洗浄とは、DNAの結合した担体を洗浄液と接触させ、再び分離することに
より、担体から、DNA以外の非特異的に結合した物質を除去する操作である。具体的な
分離方法は、使用する担体の形態により異なるが、担体がビーズなどの粒子形態である場
合には、遠心分離、ろ過分離及びカラム操作等を用いることができる。担体が磁性体を含
む場合は、磁石等を用いて、簡便に担体を洗浄することができる。
The term “washing” as used herein refers to an operation of removing a non-specifically bound substance other than DNA from the carrier by bringing the carrier to which the DNA is bound into contact with a washing solution and separating it again. The specific separation method varies depending on the form of the carrier to be used, but when the carrier is in the form of particles such as beads, centrifugation, filtration separation, column operation, and the like can be used. When the carrier contains a magnetic material, the carrier can be easily washed using a magnet or the like.
そして、溶出工程として、DNAが吸着した担体に、適量の溶出液を加え、ボルテック
ス・ミキサーなどによって混合し、DNAを担体から溶出させる。この際、溶出液を加熱
することにより、DNA抽出を促進する。加熱温度は特に限定されないが、70℃より高
ければ良く、80℃以上が好ましく、95℃以上がより好ましい。加熱温度の上限は特に
限定されないが、200℃未満であることが好ましく、150℃未満であることがより好
ましく、125℃未満であることがさらに好ましく、110℃未満であることがさらに好
ましいが、特に2本鎖DNAを単離したい時には100℃未満であることが好ましい。加
熱方法として、予め加熱した溶出液に担体を加えても良く、溶出液に担体を加えた後で加
熱しても良い。加熱時間は特に限定されないが、30秒〜10分間程度が好ましい。
Then, as an elution step, an appropriate amount of eluate is added to the carrier on which the DNA is adsorbed and mixed by a vortex mixer or the like to elute the DNA from the carrier. At this time, DNA extraction is promoted by heating the eluate. Although heating temperature is not specifically limited, What is necessary is just to be higher than 70 degreeC, 80 degreeC or more is preferable and 95 degreeC or more is more preferable. The upper limit of the heating temperature is not particularly limited, but is preferably less than 200 ° C, more preferably less than 150 ° C, further preferably less than 125 ° C, and further preferably less than 110 ° C. In particular, when it is desired to isolate double-stranded DNA, the temperature is preferably less than 100 ° C. As a heating method, the carrier may be added to the preheated eluate, or may be heated after the carrier is added to the eluate. The heating time is not particularly limited, but is preferably about 30 seconds to 10 minutes.
なお、RNAの混入を防ぐため、適量の溶出液を加えた後、一旦70℃以下に加熱して
RNAを溶出し、溶出液を除去し、担体を洗浄液により洗浄した後、新たに適量の溶出液
を加え、70℃より高温に加熱することによって、DNAを担体から溶出させてもよい。
In order to prevent RNA contamination, after adding an appropriate amount of eluate, heat it to below 70 ° C to elute the RNA, remove the eluate, wash the carrier with a washing solution, and then add a new appropriate amount of elution. The DNA may be eluted from the carrier by adding a solution and heating to a temperature higher than 70 ° C.
あるいは、RNAを除去するために、DNA抽出工程のどこかの工程に、RNaseを
添加しても良いが、効率よくRNAを分解するため、溶出液に含有させることが好ましく
、例えば、溶出液にRibonuclease Aを10〜20μg/mL含有させればよい。通常、R
Naseが含まれたままで、PCRなどの操作を行うことができるが、RNaseを除去
したい時には、吸着工程−洗浄工程−溶出工程を再度繰り返すか、その他公知の方法によ
って、DNAを精製してもよい。
Alternatively, in order to remove RNA, RNase may be added to any step in the DNA extraction step. However, in order to efficiently decompose RNA, it is preferable to contain it in the eluate. Ribonuclease A may be contained at 10 to 20 μg / mL. Usually R
PCR and other operations can be performed while Nase is contained. However, when it is desired to remove RNase, the adsorption step-washing step-elution step may be repeated again, or DNA may be purified by other known methods. .
このようにして溶出したDNAは、透析やエタノール沈殿法等の脱塩、濃縮操作を施す
ことなく、PCRなどの酵素反応に直接使用することができる。
The DNA eluted in this way can be directly used for enzymatic reactions such as PCR without performing desalting and concentration operations such as dialysis and ethanol precipitation.
1.5mLエッペンドルフ・マイクロチューブ(Eppendorf microcentrifuge tube)に
入った全血サンプル50μLに、375μLの溶解液(8Mグアニジン塩酸塩、50mM
エチレンジアミン四酢酸二水素二水和物(EDTA・2H2O)、10%ポリオキシエ
チレンソルビタンモノラウレート(Tween20)]を加えて溶解した。得られた細胞
溶解液に、磁性シリカ粒子(NPK−101、東洋紡績社)を20μL添加し、室温で5
分間、ボルテックス・ミキサー(Vortex mixer)で撹拌した。その後、マイクロチューブ
を磁気スタンド(MGS−101、東洋紡績社)に設置して磁気シリカ粒子を集め、上清
を除去した。
To 50 μL of whole blood sample in a 1.5 mL Eppendorf microcentrifuge tube, 375 μL of lysate (8 M guanidine hydrochloride, 50 mM)
Ethylenediaminetetraacetic acid dihydrogen dihydrate (EDTA · 2H 2 O), 10% polyoxyethylene sorbitan monolaurate (Tween 20)] was added and dissolved. To the obtained cell lysate, 20 μL of magnetic silica particles (NPK-101, Toyobo Co., Ltd.) was added, and the mixture was stirred at room temperature.
Stir for a minute with a vortex mixer. Thereafter, the microtube was placed on a magnetic stand (MGS-101, Toyobo Co., Ltd.) to collect magnetic silica particles, and the supernatant was removed.
次に、マイクロチューブを磁気スタンドから外し、450μLの洗浄液I(8Mグアニ
ジン塩酸塩)を加えて、十分混合した後、再度磁気スタンドに設置して、上清を除去する
ことにより、磁気ビーズを洗浄した。次に、同様にして450μLの洗浄液II(5mM
トリス塩酸緩衝液)で粒子を洗浄した。最後に、集めた粒子に50μLの溶出液(滅菌水
)を添加し、粒子を懸濁し、5分間、表1に示す温度に加熱した後、マイクロチューブを
磁気スタンドに設置して、上清を回収した。上清中のDNA量を吸光度によって測定した
。図1にその結果を示す。
Next, remove the microtube from the magnetic stand, add 450 μL of Washing Solution I (8M guanidine hydrochloride), mix well, then place it on the magnetic stand again and remove the supernatant to wash the magnetic beads. did. Next, 450 μL of washing solution II (5 mM in the same manner)
The particles were washed with (Tris-HCl buffer). Finally, 50 μL of eluate (sterilized water) is added to the collected particles, the particles are suspended, heated to the temperature shown in Table 1 for 5 minutes, the microtube is placed on a magnetic stand, and the supernatant is removed. It was collected. The amount of DNA in the supernatant was measured by absorbance. The result is shown in FIG.
比較例(従来方法)として、洗浄液IIの代わりに、70%エタノールで洗浄し、溶出
は、室温で5分間、ボルテックス・ミキサーで撹拌することにより行った。
As a comparative example (conventional method), it was washed with 70% ethanol instead of the washing solution II, and elution was performed by stirring with a vortex mixer at room temperature for 5 minutes.
表1には、各温度ごとに、比較例(コントロール)で抽出したDNA量に対する、本発
明の方法で抽出したDNA量の割合を回収率として示す。
このように、DNAが結合したシリカを、低塩濃度水溶液で洗浄しても、DNAはシリ
カに強固に結合したままであり、70℃より高い温度、好ましくは80℃以上に加熱する
ことによって、DNAを回収することができる。
Thus, even if the silica to which DNA is bound is washed with a low salt concentration aqueous solution, the DNA remains firmly bound to the silica, and by heating to a temperature higher than 70 ° C., preferably 80 ° C. or higher, DNA can be recovered.
Claims (8)
び核酸結合性固相担体を混合して、DNAを前記担体に吸着させる工程と、
前記DNAを吸着させた前記担体を、有機溶媒を含まない洗浄液で洗浄する工程と、
前記担体に吸着したDNAを70℃より高い温度で溶出液中に溶出させる工程と、
を含むDNAの抽出方法。 Mixing a sample containing deoxyribonucleic acid (DNA) with a lysate containing a chaotropic substance and a nucleic acid binding solid phase carrier, and adsorbing the DNA to the carrier;
Washing the carrier on which the DNA has been adsorbed with a washing solution containing no organic solvent;
Eluting the DNA adsorbed on the carrier into an eluate at a temperature higher than 70 ° C .;
A method for extracting DNA comprising
出方法。 The extraction method according to claim 1, wherein the cleaning liquid is water or a low salt concentration aqueous solution.
載の抽出方法。 The extraction method according to claim 2, wherein the salt concentration of the low salt concentration aqueous solution is 100 mM or less.
出方法。 The extraction method according to claim 1, wherein the eluate is water or a low salt concentration aqueous solution.
載の抽出方法。 The extraction method according to claim 4, wherein the salt concentration of the low salt concentration aqueous solution is 100 mM or less.
5のいずれか1項に記載の方法。 The DNA adsorbed on the carrier is eluted at less than 100 ° C.
6. The method according to any one of 5 above.
2mMのEDTA、0〜0.2Mの還元剤を含有する中性溶解液であることを特徴とする
、請求項1〜6のいずれか1項に記載の方法。 The solution is 3-7M guanidine salt, 0-5% nonionic surfactant, 0-0.
The method according to claim 1, which is a neutral lysate containing 2 mM EDTA and 0 to 0.2 M reducing agent.
方法。 The method according to claim 1, wherein the carrier is magnetic particles.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012170881A JP6024266B2 (en) | 2012-08-01 | 2012-08-01 | DNA extraction method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012170881A JP6024266B2 (en) | 2012-08-01 | 2012-08-01 | DNA extraction method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014030364A true JP2014030364A (en) | 2014-02-20 |
| JP6024266B2 JP6024266B2 (en) | 2016-11-16 |
Family
ID=50280724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012170881A Expired - Fee Related JP6024266B2 (en) | 2012-08-01 | 2012-08-01 | DNA extraction method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6024266B2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016035812A1 (en) * | 2014-09-03 | 2016-03-10 | 株式会社ミズホメディー | Pretreatment method and nucleic acid extraction kit used in said method |
| WO2018061877A1 (en) * | 2016-09-30 | 2018-04-05 | 栄研化学株式会社 | Nucleic acid extraction method and kit using same |
| KR20200069180A (en) * | 2018-12-06 | 2020-06-16 | 주식회사 씨젠 | Method for eluting a nucleic acid from a nucleic acid-bound particle |
| CN119082264A (en) * | 2024-10-23 | 2024-12-06 | 天津大学 | A method for extracting genomic DNA from atmospheric microorganisms |
| US12509678B2 (en) | 2021-09-21 | 2025-12-30 | Seiko Epson Corporation | Magnetic bead reagent |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02289596A (en) * | 1989-03-23 | 1990-11-29 | Akzo Nv | Method for isolating nucleic acid |
| JPH11146783A (en) * | 1997-11-17 | 1999-06-02 | Toyobo Co Ltd | Extraction of ribonucleic acid |
| JP2000125860A (en) * | 1998-08-11 | 2000-05-09 | Toyobo Co Ltd | Isolation of nucleic acid and composition for extracting nucleic acid |
| JP2001139593A (en) * | 1999-11-12 | 2001-05-22 | Toyobo Co Ltd | Method for improved extraction of nucleic acid by using particle carrier |
| JP2003204799A (en) * | 2002-01-11 | 2003-07-22 | Jsr Corp | Method for separating nucleic acids from leukocyte-containing sample |
| JP2004073193A (en) * | 2002-07-29 | 2004-03-11 | Jsr Corp | Nucleic acid separation method and nucleic acid extraction reagent |
| WO2010082631A1 (en) * | 2009-01-16 | 2010-07-22 | アークレイ株式会社 | Process for producing nucleic acid sample, and process for producing nucleic acid amplification product using the nucleic acid sample |
-
2012
- 2012-08-01 JP JP2012170881A patent/JP6024266B2/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02289596A (en) * | 1989-03-23 | 1990-11-29 | Akzo Nv | Method for isolating nucleic acid |
| JPH11146783A (en) * | 1997-11-17 | 1999-06-02 | Toyobo Co Ltd | Extraction of ribonucleic acid |
| JP2000125860A (en) * | 1998-08-11 | 2000-05-09 | Toyobo Co Ltd | Isolation of nucleic acid and composition for extracting nucleic acid |
| JP2001139593A (en) * | 1999-11-12 | 2001-05-22 | Toyobo Co Ltd | Method for improved extraction of nucleic acid by using particle carrier |
| JP2003204799A (en) * | 2002-01-11 | 2003-07-22 | Jsr Corp | Method for separating nucleic acids from leukocyte-containing sample |
| JP2004073193A (en) * | 2002-07-29 | 2004-03-11 | Jsr Corp | Nucleic acid separation method and nucleic acid extraction reagent |
| WO2010082631A1 (en) * | 2009-01-16 | 2010-07-22 | アークレイ株式会社 | Process for producing nucleic acid sample, and process for producing nucleic acid amplification product using the nucleic acid sample |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016035812A1 (en) * | 2014-09-03 | 2016-03-10 | 株式会社ミズホメディー | Pretreatment method and nucleic acid extraction kit used in said method |
| JP2016052267A (en) * | 2014-09-03 | 2016-04-14 | 株式会社ミズホメディー | Pretreatment method and nucleic acid extraction kit used therefor |
| KR20170028443A (en) | 2014-09-03 | 2017-03-13 | 가부시키가이샤 미즈호 메디 | Pretreatment method and nucleic acid extraction kit used in said method |
| US10316350B2 (en) | 2014-09-03 | 2019-06-11 | Mizuho Medy Co., Ltd. | Pretreatment method and nucleic-acid-extracting kit usable for the same |
| WO2018061877A1 (en) * | 2016-09-30 | 2018-04-05 | 栄研化学株式会社 | Nucleic acid extraction method and kit using same |
| CN109790540A (en) * | 2016-09-30 | 2019-05-21 | 荣研化学株式会社 | Extract kit used in the method and this method of nucleic acid |
| JPWO2018061877A1 (en) * | 2016-09-30 | 2019-06-24 | 栄研化学株式会社 | Method for extracting nucleic acid and kit used therefor |
| EP3521447A4 (en) * | 2016-09-30 | 2020-05-13 | Eiken Kagaku Kabushiki Kaisha | NUCLEIC ACID EXTRACTION METHOD AND KIT USING THE SAME |
| KR20200069180A (en) * | 2018-12-06 | 2020-06-16 | 주식회사 씨젠 | Method for eluting a nucleic acid from a nucleic acid-bound particle |
| KR102775904B1 (en) * | 2018-12-06 | 2025-03-05 | 주식회사 씨젠 | Method for eluting a nucleic acid from a nucleic acid-bound particle |
| US12509678B2 (en) | 2021-09-21 | 2025-12-30 | Seiko Epson Corporation | Magnetic bead reagent |
| CN119082264A (en) * | 2024-10-23 | 2024-12-06 | 天津大学 | A method for extracting genomic DNA from atmospheric microorganisms |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6024266B2 (en) | 2016-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2937410T3 (en) | Rapid method to isolate extracellular nucleic acids | |
| JP2014176303A (en) | Synthesizing method of cdna | |
| US9163228B2 (en) | Method for isolating and purifying nucleic acids | |
| WO2007100934A2 (en) | Methods and compositions for the rapid isolation of small rna molecules | |
| CN103215253A (en) | Reagent kit for extracting virus DNA (Deoxyribonucleic Acid) or RNA (Ribonucleic Acid) by using paramagnetic particle method and use method of reagent kit | |
| JP2015526100A (en) | Method for isolating RNA containing small RNA with high yield | |
| JP6024266B2 (en) | DNA extraction method | |
| JP2013533741A (en) | Ultrafast nucleic acid purification method | |
| EP2094846A1 (en) | Use of tde for the isolation of nucleic acids | |
| US10323241B2 (en) | Method for recovering short-chain nucleic acids | |
| JPH09327291A (en) | Extraction and purification of rna | |
| JP2007509620A (en) | Rapid and low cost nucleic acid isolation method | |
| JP5924888B2 (en) | Nucleic acid extraction method, nucleic acid extraction reagent kit, and nucleic acid extraction reagent | |
| CN114479129A (en) | Reagent for rapidly extracting nucleic acid by using paramagnetic particle method and nucleic acid extraction method | |
| JPH11146783A (en) | Extraction of ribonucleic acid | |
| JP2003062401A (en) | Purifying method for vital substance and purifying device | |
| US9222084B2 (en) | Method for isolating parallel double and single-stranded nucleic acids and for selectively removing double-stranded nucleic acids from a mixture of double and single-stranded nucleic acids | |
| EP4163371A1 (en) | Nucleic acid extraction method and application | |
| JP3856174B2 (en) | Extraction and purification method of plant DNA | |
| US10131935B2 (en) | Method for parallel isolation of viral nucleic acids | |
| US20130023656A1 (en) | Method for selective isolation and purification of nucleic acids | |
| JP2014039481A (en) | Rna extraction method | |
| WO2009121208A1 (en) | Reagents, chaotropic agents, kits and methods for isolating nucleic acids based on magnetic cellulose materials | |
| JP3922419B2 (en) | Method for purifying polyA + RNA with high purity | |
| JP3922420B2 (en) | Improved method for isolating ribonucleic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20150108 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150706 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160531 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20160609 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20160624 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160725 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160913 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160926 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6024266 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |